Literature DB >> 26992904

The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.

Ömer Nuri Pamuk1, Salim Dönmez2, Gökçe Büşra Calayır3, Gülsüm Emel Pamuk4.   

Abstract

Epidemiological data about antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is very limited. Until now, there has been no study about the epidemiology of AAV in Turkey. In this study, we evaluated the frequency of AAV in the northeastern part of Turkey. The general clinical features of patients diagnosed with AAV at our center within the last 10 years (2004-2014) were retrospectively recorded down. The incidence rates and the prevalence per 1,000,000 population aged ≥16 years were calculated. In addition, we evaluated the clinical features and survival rates of AAV patients. There were 30 patients with granulomatous polyangiitis (GPA), 15 with microscopic polyangiitis (MPA), and 5 with eosinophilic polyangiitis (EGPA). The overall prevalence of AAV in our region was 69.3/1,000,000 in individuals ≥16 years. Males had a similar prevalence (73.2/1,000,000) with females (65.4/1,000,000). The mean annual incidence rate was 8.1/million for all AAV. The annual incidence of AAV in females was 6.9/million; in males, it was 9.2/million. The annual incidence for GPA was calculated as 4.8/1,000,000, the incidence for MPA was 2.4/1,000,000, and the incidence for CSS was 0.8/1,000,000. Ten-year survival of patients with AAV was 65.3 %. The only independent poor prognostic factor in Cox's multivariate analysis was advanced age at the time of diagnosis (OR 7.5, 95 % CI 10.6-526, p = 0.043). The frequency of all AAV in northwestern Turkey was similar to that in southern Europe; however, it was lower than the frequency in Northern Europe.

Entities:  

Keywords:  Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV); Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA); Epidemiology; Granulatomatosis with polyangiitis (Wegener) (GPA); Microscopic polyangiitis (MPA)

Mesh:

Substances:

Year:  2016        PMID: 26992904     DOI: 10.1007/s10067-016-3232-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  41 in total

Review 1.  Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants.

Authors:  A D Mahr; T Neogi; P A Merkel
Journal:  Clin Exp Rheumatol       Date:  2006 Mar-Apr       Impact factor: 4.473

Review 2.  Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement.

Authors:  Aude Gibelin; Carla Maldini; Alfred Mahr
Journal:  Semin Respir Crit Care Med       Date:  2011-06-14       Impact factor: 3.119

3.  Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.

Authors:  Shouichi Fujimoto; Richard A Watts; Shigeto Kobayashi; Kazuo Suzuki; David R W Jayne; David G I Scott; Hiroshi Hashimoto; Hiroyuki Nunoi
Journal:  Rheumatology (Oxford)       Date:  2011-07-28       Impact factor: 7.580

4.  Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.

Authors:  R A Watts; S E Lane; G Bentham; D G Scott
Journal:  Arthritis Rheum       Date:  2000-02

5.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

6.  The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients.

Authors:  S H Panagiotakis; G S Perysinakis; H Kritikos; D Vassilopoulos; G Vrentzos; M Linardakis; G Bertsias; K Glaser; E Daphnis; D T Boumpas
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

7.  Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.

Authors:  Karen Herlyn; Frederike Buckert; Wolfgang L Gross; Eva Reinhold-Keller
Journal:  Rheumatology (Oxford)       Date:  2014-01-13       Impact factor: 7.580

8.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Authors:  R A Luqmani; P A Bacon; R J Moots; B A Janssen; A Pall; P Emery; C Savage; D Adu
Journal:  QJM       Date:  1994-11

9.  Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.

Authors:  A J Mohammad; L T H Jacobsson; A D Mahr; G Sturfelt; M Segelmark
Journal:  Rheumatology (Oxford)       Date:  2007-06-06       Impact factor: 7.580

10.  The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose Guerrero; Pilar Rodriguez-Ledo; Javier Llorca
Journal:  Arthritis Rheum       Date:  2003-06-15
View more
  8 in total

1.  Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: a 15-year study.

Authors:  Florencia S Pierini; Marina Scolnik; Valeria Scaglioni; Florencia Mollerach; Enrique R Soriano
Journal:  Clin Rheumatol       Date:  2019-02-11       Impact factor: 2.980

Review 2.  Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Authors:  Alvise Berti; Roberto Caporali; Carlomaurizio Montecucco; Giuseppe Paolazzi; Sara Monti
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

3.  Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis.

Authors:  Rocío Redondo-Rodriguez; Natalia Mena-Vázquez; Alba María Cabezas-Lucena; Sara Manrique-Arija; Arkaitz Mucientes; Antonio Fernández-Nebro
Journal:  J Clin Med       Date:  2022-05-04       Impact factor: 4.964

4.  The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.

Authors:  Alvise Berti; Divi Cornec; Cynthia S Crowson; Ulrich Specks; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

5.  Predictors of renal and patient outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: Our single-center, tertiary care experience.

Authors:  Aysun Toraman; Özgül Soysal Gündüz
Journal:  Arch Rheumatol       Date:  2021-05-11       Impact factor: 1.472

Review 6.  Global epidemiology of vasculitis.

Authors:  Richard A Watts; Gulen Hatemi; Jane C Burns; Aladdin J Mohammad
Journal:  Nat Rev Rheumatol       Date:  2021-12-01       Impact factor: 20.543

Review 7.  Environmental factors influencing the risk of ANCA-associated vasculitis.

Authors:  Wen-Man Zhao; Zhi-Juan Wang; Rui Shi; Yu-Yu Zhu; Sen Zhang; Rui-Feng Wang; De-Guang Wang
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

8.  ANCA associated vasculitis in patients from Saudi Arabia.

Authors:  Abdurhman Saud Al Arfaj; Najma Khalil
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.